122 related articles for article (PubMed ID: 3588404)
61. Flow cytometric DNA analysis of stage I endometrial carcinoma.
Britton LC; Wilson TO; Gaffey TA; Lieber MM; Wieand HS; Podratz KC
Gynecol Oncol; 1989 Sep; 34(3):317-22. PubMed ID: 2767522
[TBL] [Abstract][Full Text] [Related]
62. Squamous cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry.
Nativ O; Winkler HZ; Reiman HM; Lieber MM
J Urol; 1990 Jul; 144(1):23-6. PubMed ID: 2359174
[TBL] [Abstract][Full Text] [Related]
63. Flow-cytometric analysis of the DNA content in paraffin-embedded tissue and in fresh tumour samples obtained from renal cell carcinoma: comparison of DNA ploidy using ethidium bromide and mithramycin.
Fischer C; Knaust KO; Schauer A; Ringert RH
Anticancer Res; 1996; 16(5A):2575-80. PubMed ID: 8917354
[TBL] [Abstract][Full Text] [Related]
64. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
65. Flow-cytometric analysis of colorectal cancer with hepatic metastases and its relationship to metastatic characteristics and prognosis.
Yamaguchi A; Ishida T; Takegawa S; Nishimura G; Kanno M; Kosaka T; Yonemura Y; Izumi R; Miyazaki I
Oncology; 1990; 47(6):478-82. PubMed ID: 2243667
[TBL] [Abstract][Full Text] [Related]
66. [Nuclear DNA analysis of hepatocellular carcinoma].
Fujimoto J; Okamoto E; Yamanaka N; Fujiwara S; Kato T; Mitsunobu M; Toyosaka A
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1568-70. PubMed ID: 2555666
[TBL] [Abstract][Full Text] [Related]
67. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
[TBL] [Abstract][Full Text] [Related]
68. Correlation of DNA ploidy, histopathology, stage and clinical outcome in gastric carcinoma.
Tsushima K; Nagorney DM; Cha SS; Reiman HM
Surg Oncol; 1992 Feb; 1(1):17-25. PubMed ID: 1341231
[TBL] [Abstract][Full Text] [Related]
69. Flow cytometric measurements of nuclear DNA and ploidy analysis in Hürthle cell neoplasms of the thyroid.
McLeod MK; Thompson NW; Hudson JL; Gaglio JA; Lloyd RV; Harness JK; Nishiyama R; Cheung PS
Arch Surg; 1988 Jul; 123(7):849-54. PubMed ID: 3382350
[TBL] [Abstract][Full Text] [Related]
70. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
71. Relationship between DNA ploidy, antigen expression and survival in renal cell carcinoma.
Oosterwijk E; Warnaar SO; Zwartendijk J; van der Velde EA; Fleuren GJ; Cornelisse CJ
Int J Cancer; 1988 Nov; 42(5):703-8. PubMed ID: 3182107
[TBL] [Abstract][Full Text] [Related]
72. Atypical adenoma of the thyroid. A clinicopathologic and flow cytometric DNA study in comparison with other follicular neoplasms.
Fukunaga M; Shinozaki N; Endo Y; Ushigome S
Acta Pathol Jpn; 1992 Sep; 42(9):632-8. PubMed ID: 1476057
[TBL] [Abstract][Full Text] [Related]
73. Flow cytometric DNA analysis of renal-cell carcinoma. A study of fine needle aspiration biopsies in comparison with multiple surgical samples.
Ljungberg B; Stenling R; Roos G
Anal Quant Cytol Histol; 1987 Dec; 9(6):505-8. PubMed ID: 3435627
[TBL] [Abstract][Full Text] [Related]
74. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493
[TBL] [Abstract][Full Text] [Related]
75. Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate.
Ritchie AW; Dorey F; Layfield LJ; Hannah J; Lovrekovich H; deKernion JB
Br J Urol; 1988 Sep; 62(3):245-60. PubMed ID: 3191338
[TBL] [Abstract][Full Text] [Related]
76. Flow cytometric DNA analysis of submucosal carcinoma of the esophagus.
Hui AM; Itabashi M; Kato H; Tachimori Y; Watanabe H; Hirota T
Jpn J Clin Oncol; 1994 Feb; 24(1):26-31. PubMed ID: 8126917
[TBL] [Abstract][Full Text] [Related]
77. Flow and image cytometry in thymic neoplasia: correlation with clinical outcome.
Kenny-Moynihan MB; DeRose PB; Gal AA; Chakraborty H; Cohen C
Anal Quant Cytol Histol; 2001 Aug; 23(4):313-20. PubMed ID: 11531146
[TBL] [Abstract][Full Text] [Related]
78. Flow cytometric analysis of small renal tumors.
Ellis WJ; Bauer KD; Oyasu R; McVary KT
J Urol; 1992 Dec; 148(6):1774-7. PubMed ID: 1433605
[TBL] [Abstract][Full Text] [Related]
79. Comparison between diploid and aneuploid hepatocellular carcinomas: a flow cytometric study.
Nagasue N; Yamanoi A; Takemoto Y; Kimoto T; Uchida M; Chang YC; Taniura H; Kohno H; Nakamura T
Br J Surg; 1992 Jul; 79(7):667-70. PubMed ID: 1322756
[TBL] [Abstract][Full Text] [Related]
80. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
